Молимо вас користите овај идентификатор за цитирање или овај линк до ове ставке: https://open.uns.ac.rs/handle/123456789/6157
Назив: Single-dose oral guanidinoacetic acid exhibits dose-dependent pharmacokinetics in healthy volunteers
Аутори: Ostojić, Sergej 
Vojvodic-Ostojic, Aleksandra
Датум издавања: мар-2015
Часопис: Nutrition Research
Сажетак: Guanidinoacetic acid (GAA), the natural precursor of creatine, has potential as a dietary supplement for human nutrition, yet no data are available regarding its dose-dependent pharmacokinetic (PK) behavior. We hypothesized that a single dose of orally administered GAA exhibited dose-dependent PK behavior in healthy volunteers. Forty-eight young adults were enrolled in a randomized, placebo-controlled, double-blind, parallel-group trial to receive single oral doses of GAA (1.2, 2.4, and 4.8 g) or a placebo. Pharmacokinetic metrics for plasma GAA and creatine were assessed immediately before (0 hours) and at 1, 2, 4, 6, 8, 12, and 24 hours after GAA ingestion. The lag time appeared to be similar after the bolus ingestion of GAA (0.14 ± 0.17 hours for low-dose GAA, 0.31 ± 0.18 hours for medium-dose GAA, and 0.38 ± 0.32 hours for high-dose GAA; P = .05). An increase in the area under the concentration-time curve for plasma GAA was found for the dose range tested, with 2.4- and 9.3-fold increases in the area under the concentration-time curve for every 2-fold increase in the GAA dose (P < .0001). No differences were found for elimination half-time between the low-dose and medium-dose groups (<1.75 hours), whereas the elimination half-time was significantly longer (>2.1 hours) for the high-dose GAA regimen (P = .001). The volume of distribution was affected by the dosage of GAA applied (102.6 ± 17.3 L for low-dose GAA, 97.5 ± 15.7 L for medium-dose GAA, and 61.1 ± 12.7 L for high-dose GAA; P < .0001). Ingestion of GAA elevated plasma creatine by 80%, 116%, and 293% compared with the placebo for the 1.2, 2.4, and 4.8 g doses, respectively (P < .0001). Guanidinoacetic acid single-dose PK metrics were nonlinear with respect to dose size. Across the dose range of 1.2 to 4.8 g, systemic exposure to GAA increased in a greater than dose-proportional manner.
URI: https://open.uns.ac.rs/handle/123456789/6157
ISSN: 0271-5317
DOI: 10.1016/j.nutres.2014.12.010
Налази се у колекцијама:FSFV Publikacije/Publications

Приказати целокупан запис ставки

SCOPUSTM   
Навођења

10
проверено 10.05.2024.

Преглед/и станица

20
Протекла недеља
15
Протекли месец
0
проверено 10.05.2024.

Google ScholarTM

Проверите

Алт метрика


Ставке на DSpace-у су заштићене ауторским правима, са свим правима задржаним, осим ако није другачије назначено.